ClinicalTrials.gg
Drug

Liposomal doxorubicin clinical trials

A product of Doxorubicin; its studies count on that page too.

studies test it
210
open now
18
in phase 3
28
first study started
1997
Related medicines add 1 study

Counted the way a researcher would: Liposomal doxorubicin with its salts, dosage forms, brands and biosimilars. Looking for a trial to join? Including related medicines shows more you could take part in.

This browser remembers your choice.

How each study uses liposomal doxorubicin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the liposomal doxorubicin studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
17 Nov 1995 · DOXIL (LIPOSOMAL) · NDA 050718 (FDA, Drugs@FDA)
European Union
20 Jun 1996 · Caelyx pegylated liposomal · EMEA/H/C/000089 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Doxil
56
liposomal doxorubicin
39
pegylated liposomal doxorubicin hydrochloride
36
Caelyx
34
Pegylated liposomal doxorubicin
32

Development codes

SCH 200746
1
ATI-0918
1

In one entry with another drug

Given together, or one or the other

Pegylated Liposomal Doxorubicin and docetaxel
2

Studies by the year they started

210 studies that test it; most in 2005 (19)

Studies that test liposomal doxorubicin, by start year
YearStudies
19972
19981
19994
20007
20015
20024
20038
200411
200519
200616
200710
200819
200911
20106
20112
20128
20134
20147
20159
201610
20177
20186
201911
20215
20222
20236
20241
20254
20265

By phase

A phase 1/2 study counts in both.

Phase 1
63
Phase 2
129
Phase 3
28
Phase 4
9
No phase
9

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 42 · Other 168

National Cancer Institute (NCI) (11) · M.D. Anderson Cancer Center (7) · Merck Sharp & Dohme LLC (6) · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (6) · Fudan University (6) · Sun Yat-sen University (5) · H. Lee Moffitt Cancer Center and Research Institute (4) · ARCAGY/ GINECO GROUP (3)

Often tested with

Tested in the same studies.

Bortezomib (23) · Cyclophosphamide (18) · Dexamethasone (18) · Paclitaxel (15) · Carboplatin (14) · Docetaxel (12) · Trastuzumab (12) · Bevacizumab (12)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 19 phase 3 studies under way

Liposomal doxorubicin is the comparator. A study of two new drugs counts under both.

Reaching primary completion within a year · 7

Studies that test liposomal doxorubicin.

Studies

Open first, then newest update. How each study uses liposomal doxorubicin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 210

See all 210 studies that test liposomal doxorubicin →

Given beside what is tested · 103 — liposomal doxorubicin is usual care or a partner of the new treatment

Showing 20 of 103.

As the comparator · 45 — what is tested is compared with liposomal doxorubicin

Showing 20 of 45.

Codes

What other systems call liposomal doxorubicin · ClinicalTrials.gg INT004851

  • MeSH (NLM) C506643liposomal doxorubicinOne source ClinicalTrials.gov

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.